Immunopathogenesis of SLE & drug targets

Author:

Kaul Arvind1,D’Cruz David2,RV Hughes Graham3

Affiliation:

1. Arvind Kaul is currently a Consultant Physician in Rheumatology and Acute Medicine at the Royal Free Hospital, London, UK. He obtained his MSc and PhD from the University of London investigating inflammation and vascular biology. He has a strong interest in lupus and other connective tissue diseases, particularly their effect on cardiovascular disease as well as the immunological links between skin and joint disorders.

2. David D’Cruz is Consultant Rheumatologist/Reader Louise Coote Lupus Unit, St Thomas’ Hospital, London, UK. He has received training at St Mary’s Hospital Medical School London, University College Hospital, St Thomas’ Hospital and St Bartholomew’s and Royal London Hospitals. He was senior Lecturer in Rheumatology at St Bartholomew’s and The Royal London in 1995–2000.

3. Graham RV Hughes trained at the London Hospital, UK. In 1969–1970, he spent 2 years with Professor Charles Christian in New York (USA), working on the introduction of anti-DNA assays in lupus. In 1971, he set up Europe’s first dedicated lupus clinic. In 1983, he described the antiphospholipid syndrome (Hughes syndrome). He has published widely on lupus and connective tissue diseases, and has published 12 books. He is Founder and Editor of the international journal Lupus, now in its 20th year. His honors...

Publisher

Future Medicine Ltd

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3